References
- Anon. (2004). Operational Guidelines on Elimination of Lymphatic Filariasis. Delhi, India: National Vector Borne Disease Control Programme.
- Babu, B. V. & Kar, S. K. (2004). Coverage, compliance and some operational issues of mass drug adminis-tration during the programme to eliminate lymphatic filariasis in Orissa, India. Tropical Medicine and International Health, 9, 702–709.
- Babu, B. V. & Satyanarayana, K. (2003). Factors responsible for coverage and compliance in mass drug administration during the programme to elim-inate lymphatic filariasis in the East Godavari district, South India. Tropical Doctor, 33, 79–82.
- Babu, B. V., Rath, K., Kerketta, A. S., Swain, B. K., Mishra, S. & Kar, S. K. (2006). Adverse reactions following mass drug administration during the programme to eliminate lymphatic filariasis in Orissa state, India. Transactions of the Royal Society of Tropical Medicine and Hygiene, 100, 464-469.
- Das, P. K., Pani, S. P. & Krishnarnoorthy, K. (2002). Prospects of elimination of lymphatic filariasis in India. ICMR Bulletin, 32, 41–54.
- Kumar, P., Prajapati, P. B., Saxena, D., Kavishwar, A. B. & Kurian, G. (2008). An evaluation of coverage and compliance of mass drug administration 2006 for elimination of lymphatic filariasis in Gujarat. Indian Journal of Community Medicine, 33, 38-42.
- Lahariya, C. & Mishra, A. (2008). Strengthening of mass drug administration implementation is required to eliminate lymphatic filariasis from India: an evaluation study. Journal of Vector Borne Diseases, 45, 313–320.
- Lammie, P., Milner, T. & Houston, R. (2007). Unfulfilled potential, using diethylcarbamazine- for-tified salt to eliminate lymphatic filariasis. Bulletin of the World Health Organization, 85, 545-549.
- Mathieu, E., Lammie, P. J., Radday, J., Beach, M. J., Streit, T., Wendt, J. & Addiss, D. G. (2004). Factors associated with participation in a campaign of mass treatment against lymphatic filariasis, in Leogane, Haiti. Annals of Tropical Medicine and Parasitology, 98, 703–714.
- McLaughlin, S. I., Radday, J., Michel, M. C., Addiss, D. G., Beach, M. J., Lammie, P. J., Lammie, J., Rheingans, R. & Lafontant, J. (2003). Frequency, severity, and costs of adverse reactions following mass treatment for lymphatic filariasis using diethyl-carbamazine and albendazole in Leogane, Haiti, 2000. American Journal of Tropical Medicine and Hygiene, 68, 568–573.
- Mukhopadhyay, S. K., Patnaik, P., Satyababu, P. & Rao, K. N. N. B. (2008). Knowledge on lymphatic filariasis and mass drug administration programme in filarial endemic districts of Andhra Pradesh, India. Journal of Vector Borne Diseases, 45, 73–75.
- Nandha, B., Sadanandane, C., Jambulingam, P. & Das, P. K. (2007). Delivery strategy of mass annual single dose DEC administered to eliminate lymphatic filariasis in the urban areas of Pondicherry in South India: 5 years of experience. Filaria Journal, 6, 7.
- Ottesen, E. A. (2000). The global programme to eliminate lymphatic filariasis. Tropical Medicine and International Health, 5, 591–594.
- Ramaiah, K. D., Das, P. K., Appavoo, N. C., Ramu, K., Augustine, D. J., Kumar, K. N. & Chandrakala, A. V. (2000a). A programme to eliminate lymphatic filariasis in Tamil Nadu state, India. Compliance with annual single dose mass treatment and some related operational aspects. Tropical Medicine and International Health, 5, 842–847.
- Ramaiah, K. D., Das, P. K., Michael, E. & Guyatt, H. (2000b). The economic burden of lymphatic filariasis in India. Parasitology Today, 16, 251–253.
- Remme, J. H. F., Alley, E. S. & Plaisier, A. P. (1995). Estimation and prediction in tropical disease control: the example of onchocerciasis. In Epidemic Models: Their Structure and Relation to Data, ed. Mollison, D. pp. 372-392. Cambridge, U.K.: Cambridge University Press.
- Showkath Ali, M. K., Rajendran, R., Regu, K., Mohanan, M. K., Dhariwal, A. C. & Lal, S. (2007). Study on the factors affecting the MDA programme in Kerala state. Journal of Communicable Diseases, 39, 51-56.
- World Health Organization (1985). Community Involvement for health development: report of the Interregional meeting, Brioni, Yugoslavia, 9-14 June 1985. Geneva: WHO.
- World Health Organization (2006). A Workshop to Review the Impact of Mass Drug Administration (MDA) on Lymphatic Filariasis (LF) Disease, Infection and Transmission. 11-13 December 2006. Geneva: WHO.
- World Health Organization (2007). Global Programme to Eliminate Lymphatic Filariasis: progress report on mass drug administration in 2006. Weekly Epidemiological Record, 82, 361–380.